ahlam1399
07-03-2015, 09:11 PM
Hospira wins French biosimilar drug tender at 45 pct discount
PARIS, July 3 (Reuters) - A major French hospital group has chosen a cheap copycat version of a top-selling drug for treating its patients with rheumatoid arthritis and Crohn's disease in a victory for a new type of medicine k**wn as biosimilars.
http://i1.wp.com/reuters.us.feedsportal.com/c/35217/f/654213/s/47d00b14/sc/19/mf.gif?resize=1%2C1http://feeds.feedburner.com/~ff/reuters/companyNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/companyNews?a=epwsnrHC89E:GHgU0esbFGw:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/companyNews?i=epwsnrHC89E:GHgU0esbFGw:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/companyNews?a=epwsnrHC89E:GHgU0esbFGw:V_sGLiPBpWU) http://feeds.feedburner.com/~ff/reuters/companyNews?i=epwsnrHC89E:GHgU0esbFGw:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/companyNews?a=epwsnrHC89E:GHgU0esbFGw:F7zBnMyn0Lo)
http://feeds.feedburner.com/~r/reuters/companyNews/~4/epwsnrHC89E
PARIS, July 3 (Reuters) - A major French hospital group has chosen a cheap copycat version of a top-selling drug for treating its patients with rheumatoid arthritis and Crohn's disease in a victory for a new type of medicine k**wn as biosimilars.
http://i1.wp.com/reuters.us.feedsportal.com/c/35217/f/654213/s/47d00b14/sc/19/mf.gif?resize=1%2C1http://feeds.feedburner.com/~ff/reuters/companyNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/companyNews?a=epwsnrHC89E:GHgU0esbFGw:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/companyNews?i=epwsnrHC89E:GHgU0esbFGw:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/companyNews?a=epwsnrHC89E:GHgU0esbFGw:V_sGLiPBpWU) http://feeds.feedburner.com/~ff/reuters/companyNews?i=epwsnrHC89E:GHgU0esbFGw:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/companyNews?a=epwsnrHC89E:GHgU0esbFGw:F7zBnMyn0Lo)
http://feeds.feedburner.com/~r/reuters/companyNews/~4/epwsnrHC89E